Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Scott

Showing results (321-330 of 338) with videos related to

Pageof 34
Sort By:
Clinical Pharmacokinetics|May 14, 2004
Pharmacokinetics of lumiracoxib in plasma and synovial fluidGraham Scott, Christiane Rordorf, Christine Reynolds, et al.
Developmental Psychobiology|March 24, 2026
Boosting Representation and Validity in Pediatric Electroencephalography Research: The Conceptualization, Development, and Implementation of the Curly Hair Specialist InitiativeMaría Isabella Natale Castillo, Monique Marsh, Charles Alexander Nelson, et al.
Epidemiology and Infection|December 12, 2022
High pathogenicity avian influenza: targeted active surveillance of wild birds to enable early detection of emerging disease threatsDaniel Wade, Adham Ashton-Butt, Graham Scott, et al.
Pediatric Dermatology|September 30, 2005
Low systemic absorption and good tolerability of pimecrolimus, administered as 1% cream (Elidel) in infants with atopic dermatitis--a multicenter, 3-week, open-label studyDoris Staab, David Pariser, Alice B Gottlieb, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2004
Pharmacology and gastrointestinal safety of lumiracoxib, a novel cyclooxygenase-2 selective inhibitor: An integrated studyClare Atherton, John Jones, Brian McKaig, et al.
JOR Spine|November 15, 2024
Pharmacokinetics of PP353, a formulation of linezolid for intervertebral disc administration, in patients with chronic low back pain and Modic change Type 1: A first-in-human, Phase 1b, open-label, single-dose studyShiva S Tripathi, Robert Sneath, Aprajay Golash, et al.
Open Research Europe|July 3, 2026
The evolving study of political polarizationEmre Erdogan, Bernadette Nadya Jaworsky, Cláudia Álvares, et al.
The Journal of Investigative Dermatology|October 31, 2002
Pimecrolimus identifies a common genomic anti-inflammatory profile, is clinically highly effective in psoriasis and is well toleratedKlemens Rappersberger, Michael Komar, Marie-Eve Ebelin, et al.
Genome Research|May 28, 2026
Whole-genome variant detection in long-read sequencing data from ultra-low input patient samplesKatherine Wang, Cera J Aex, Hayan Lee, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentLouise Dickson, Roberto Tolando, Celina Scholl, et al.
Pageof 34

Showing results (321-330 of 338) with videos related to

Sort By:
Pageof 34
Clinical Pharmacokinetics|May 14, 2004
Pharmacokinetics of lumiracoxib in plasma and synovial fluidGraham Scott, Christiane Rordorf, Christine Reynolds, et al.
Developmental Psychobiology|March 24, 2026
Boosting Representation and Validity in Pediatric Electroencephalography Research: The Conceptualization, Development, and Implementation of the Curly Hair Specialist InitiativeMaría Isabella Natale Castillo, Monique Marsh, Charles Alexander Nelson, et al.
Epidemiology and Infection|December 12, 2022
High pathogenicity avian influenza: targeted active surveillance of wild birds to enable early detection of emerging disease threatsDaniel Wade, Adham Ashton-Butt, Graham Scott, et al.
Pediatric Dermatology|September 30, 2005
Low systemic absorption and good tolerability of pimecrolimus, administered as 1% cream (Elidel) in infants with atopic dermatitis--a multicenter, 3-week, open-label studyDoris Staab, David Pariser, Alice B Gottlieb, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2004
Pharmacology and gastrointestinal safety of lumiracoxib, a novel cyclooxygenase-2 selective inhibitor: An integrated studyClare Atherton, John Jones, Brian McKaig, et al.
JOR Spine|November 15, 2024
Pharmacokinetics of PP353, a formulation of linezolid for intervertebral disc administration, in patients with chronic low back pain and Modic change Type 1: A first-in-human, Phase 1b, open-label, single-dose studyShiva S Tripathi, Robert Sneath, Aprajay Golash, et al.
Open Research Europe|July 3, 2026
The evolving study of political polarizationEmre Erdogan, Bernadette Nadya Jaworsky, Cláudia Álvares, et al.
The Journal of Investigative Dermatology|October 31, 2002
Pimecrolimus identifies a common genomic anti-inflammatory profile, is clinically highly effective in psoriasis and is well toleratedKlemens Rappersberger, Michael Komar, Marie-Eve Ebelin, et al.
Genome Research|May 28, 2026
Whole-genome variant detection in long-read sequencing data from ultra-low input patient samplesKatherine Wang, Cera J Aex, Hayan Lee, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentLouise Dickson, Roberto Tolando, Celina Scholl, et al.
Pageof 34